Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa.
about
Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countriesResistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysisMeasuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testingCost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringNevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trialTrends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment RegimensHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaHigh prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South AfricaTrends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, MozambiqueLow Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort StudyThe net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data.Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.Drug susceptibility and resistance mutations after first-line failure in resource limited settingsSecond-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeA comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences.Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaSuboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, KenyaEfficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational databaseOutcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South AfricaHIV Genetic Diversity and Drug Resistance.Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment optionsGenotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patientsDrug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment programA retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in MalawiMarginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialLopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsLack of integrase inhibitors associated resistance mutations among HIV-1C isolates.Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors.Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 InfectionHIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in CameroonSurveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009.Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic Monitoring
P2860
Q27001286-6D9D4F84-9645-4A7B-AE8B-95DC113F4CA9Q28478121-D917B4AB-1757-4324-B226-561D8F5D21E4Q28479215-55D877D0-A477-46B7-B478-CAA141C535CBQ28482138-E3439C59-85C7-4BB8-9230-518F1F13576BQ28484207-B5ED4922-367E-40BE-A5F8-4DF3703126DDQ28534323-6CA3AE76-D22D-416F-9BCB-27B7261BF261Q28535483-2D0DD1E8-8607-4132-96CE-07B55CFC93E3Q28543358-B737A503-4631-4BBC-A798-09F69EC59865Q28546341-BC972F8C-0AF4-4115-9662-8EDDE23A13D2Q28550552-5B91D54B-2CCE-4078-ADD3-3853F216864EQ33901360-A4A0809C-1336-49EA-AECD-FC4D3CA4D86AQ33952538-0C68E16A-6946-4615-AE54-04A265729C44Q34097961-424A122B-EECF-4150-9F34-D6773BB99F29Q34106181-3E2A9148-0C53-4020-8132-1FF30118D9A8Q34292437-027BB698-09EC-4836-BD3F-4BF24B3B2EDEQ34321402-241D4DD3-15DF-4847-B6FE-D9276DCB2EC6Q34734833-02F0F303-439E-4832-B028-20BBACF64884Q34812918-5A15964C-D84B-448A-8351-B7267BBD6DA1Q34968326-47A4CE97-1A81-4545-A9F7-0144D4C81F2EQ34977431-2BF9200A-5DF4-42FD-9F39-0F3BEC8B1135Q34979072-313144E1-CAA0-47C3-B58B-5B6F582F9B42Q35105844-F7D68925-F851-4553-BB96-F93FAD2641D3Q35217629-AD8C95A4-F398-408D-9F94-ABF2DB6A0A48Q35260590-8A1A76B0-3E5C-4F66-BC45-AE35956F261BQ35386184-43160906-3BD4-4CED-A1CA-02EFBD102916Q35403205-B6AD4545-E3FF-4EB1-8398-7DEF90F84555Q35610741-6D02D0BF-463F-4E63-8666-CFAC9D9CCE74Q35862329-330F273E-B042-4561-934C-795EF16E7FAFQ35917545-566D83BB-792A-4FD5-AC00-1AE88F4B0C95Q35917568-43079D40-02FE-4843-867C-9FA8B78B1F51Q36109276-7424E0CE-67CA-42C0-BE9F-71095BAB12FFQ36179320-FD7FD2BF-70F3-4754-AD58-6725EC20616CQ36238042-72F48285-1165-41D5-92AA-EE9BD6D5233FQ36336395-116BADF0-EF58-4C63-8C16-2C518CF1BC2AQ36379570-40E140B0-0D43-4B3C-89C9-F79C770BF24DQ36401516-9E64AD33-96CD-4485-AB10-D2C6F3A76A2FQ36558909-3F5A4C45-813F-4632-9AC7-1652372620B6Q36581795-49B8C535-19CE-495E-B2CF-C6D890E872CCQ36611216-D8F78C43-C361-4FC0-8AD2-DF79D57A55DFQ36667251-CC6D7E4F-3468-40EE-8EC5-0FB8A6636F3D
P2860
Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@en
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@nl
type
label
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@en
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@nl
prefLabel
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@en
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@nl
P2093
P1476
Varied patterns of HIV-1 drug ...... viral therapy in South Africa.
@en
P2093
Carole L Wallis
John W Mellors
Wendy Stevens
Willem D F Venter
P304
P356
10.1097/QAI.0B013E3181BC478B
P407
P50
P577
2010-04-01T00:00:00Z